6-Methoxynaringenin

CAS No. 94942-49-1

6-Methoxynaringenin( —— )

Catalog No. M37759 CAS No. 94942-49-1

6-Methoxynaringenin is an aerial part of Scutellaria barbata D. Don (Lamiaceae) and inhibits NO production efficiently with an IC50 value of 25.8 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 909 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-Methoxynaringenin
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Methoxynaringenin is an aerial part of Scutellaria barbata D. Don (Lamiaceae) and inhibits NO production efficiently with an IC50 value of 25.8 μM.
  • Description
    6-Methoxynaringenin is a natural flavonoid that inhibits NO production with an IC50 of 25.8 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    NO Synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    94942-49-1
  • Formula Weight
    302.28
  • Molecular Formula
    C16H14O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC1=C2C(O[C@@H](CC2=O)C3=CC=C(O)C=C3)=CC(O)=C1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. So Ra Lee, et al. Constituents from Scutellaria barbata Inhibiting Nitric Oxide Production in LPS-Stimulated Microglial Cells. Chem Biodivers. 2017 Nov;14(11). ?
molnova catalog
related products
  • 1400W dihydrochlorid...

    1400 W is a highly potent and selective inhibitor of inducible NOS2 (iNOS).

  • Nitroarginine

    Nitroarginine is a competitive inhibitor of nitric oxide synthase which causes the selective reduction of blood flow to tumor cells.

  • TP508

    TP508 is a 23 amino acid synthetic peptide representing residues 508-530 of human prothrombin which is identified as a potential receptor-binding domain based on competition for high-affinity thrombin binding to fibroblasts.TP508 (Chrysalin) is an investigational peptide drug that was developed for use in stimulating repair of dermal and musculoskeletal tissues.